1-3 of 3
Tyler Dickerson
Close
Sort by
Journal Articles

Hypertension and incident cardiovascular events following ibrutinib initiation

Clinical Trials & Observations
Tyler Dickerson, Tracy Wiczer, Allyson Waller, Jennifer Philippon, Kyle Porter, Devin Haddad, Avirup Guha, Kerry A. Rogers, Seema Bhat, John C. Byrd, Jennifer A. Woyach, Farrukh Awan, Daniel Addison
Journal: Blood
Blood (2019) 134 (22): 1919–1928.
https://doi.org/10.1182/blood.2019000840
Published: 2019
Includes: Supplemental data
Journal Articles

Comparison of Fixed Dose, Reduced-Intensity Conditioning with Busulfan and Fludarabine to Reduced PK-Guided Busulfan AUC Conditioning in Patients Undergoing Hematopoietic Stem Cell Transplant for AML/MDS

Brendan Rasor, PharmD, Tyler Dickerson, PharmD, Qiuhong Zhao, MS, Jonathan E Brammer, MD, Karilyn Larkin, MD, Samantha Jaglowski, MDMPH, Alice S. Mims, MD, Sam Penza, MD, Sumithira Vasu, MDMBBS, Sarah A Wall, MD, Basem M. William, MRCP,MD, Ayman Saad, MD, Julianna Roddy, PharmD, Hannah K. Choe, MD, Marcin Puto, PharmD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5715.
https://doi.org/10.1182/blood-2019-123657
Published: 2019
Journal Articles

Hypertension Development, Management, and Cardiovascular Events Following Ibrutinib Initiation for Hematologic Malignancies

Tyler Dickerson, PharmD, Tracy Wiczer, Allyson Waller, Jennifer Philippon, Devin Haddad, Avirup Guha, Kyle Porter, Kerry A. Rogers, MD, Jennifer A. Woyach, MD, John C. Byrd, MD, Daniel Addison, Farrukh T. Awan, MD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4423.
https://doi.org/10.1182/blood-2018-99-110345
Published: 2018